Application

17859743 · TREATMENT OF DISEASES BY CONCURRENTLY ELICITING REMYELINATION EFFECTS AND IMMUNOMODULATORY EFFECTS USING SELECTIVE RXR AGONISTS

Filed 2022-07-07 · Granted · Patent 12383521 (2025-08-12) The official file ↗The patent and its PDF ↗ · Art unit 1629 · Examiner James D Anderson Typical · CPC A61K 31/192 · Trustees of Dartmouth College · K&L Gates LLP

Office actions

first was Notice of allowance

RCEs

no appeal

To first action

33.1 mo

to disposition 37.2 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.